n(6)-carboxymethyllysine has been researched along with n(6)-(1-carboxyethyl)lysine in 33 studies
| Studies (n(6)-carboxymethyllysine) | Trials (n(6)-carboxymethyllysine) | Recent Studies (post-2010) (n(6)-carboxymethyllysine) | Studies (n(6)-(1-carboxyethyl)lysine) | Trials (n(6)-(1-carboxyethyl)lysine) | Recent Studies (post-2010) (n(6)-(1-carboxyethyl)lysine) |
|---|---|---|---|---|---|
| 803 | 44 | 365 | 55 | 3 | 22 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 18 (54.55) | 29.6817 |
| 2010's | 14 (42.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, MU; Baynes, JW; Brinkmann Frye, E; Degenhardt, TP; Thorpe, SR | 1 |
| Bank, RA; Bayliss, MT; Baynes, JW; Bijlsma, JW; DeGroot, J; Lafeber, FP; Oldehinkel, E; Tekoppele, JM; Thorpe, SR; Verzijl, N | 1 |
| Bank, RA; Baynes, JW; Bijlsma, JW; DeGroot, J; Lafeber, FP; Lyons, TJ; Shaw, JN; TeKoppele, JM; Thorpe, SR; Verzijl, N | 1 |
| Ahmed, N; Argirov, OK; Cordeiro, CA; Minhas, HS; Thornalley, PJ | 1 |
| Barja, G; Bellmun, MJ; Gredilla, R; Pamplona, R; Portero-Otín, M | 1 |
| Barja, G; Gredilla, R; Pamplona, R; Portero-Otín, M; Requena, J | 1 |
| Barto, R; Lieuw-A-Fa, ML; Schalkwijk, CG; Stehouwer, CD; Teerlink, T; Twisk, J; van Hinsbergh, VW | 1 |
| Cheriex, EC; Konings, CJ; Kooman, JP; Leunissen, KM; Schalkwijk, CG; Scheffer, PG; ter Wee, PM; van de Kerkhof, J; van der Sande, FM | 1 |
| Barto, R; Schalkwijk, CG; Teerlink, T; Ten Brink, HJ | 1 |
| Baynes, JW | 1 |
| Araki, T; Horiuchi, S; Koito, W; Nagai, R | 1 |
| Chandoga, J; Futas, J; Jakus, V; Petrovic, R | 1 |
| Bootsma, AH; Chaturvedi, N; Fuller, JH; Schalkwijk, CG; Schram, MT; Stehouwer, CD | 1 |
| Amano, S; Fukayama, M; Kaji, Y; Nagai, R; Oshika, T; Takazawa, Y | 1 |
| Baynes, JW; den Hollander, NC; Graaff, R; Mulder, DJ; Smit, AJ; Smit, GP; Thorpe, SR | 1 |
| Bakker, SJ; Damman, K; Hartog, JW; Schalkwijk, CG; Scheijen, J; Smilde, TD; Smit, AJ; van Veldhuisen, DJ; Voors, AA | 1 |
| Bijl, M; Bijzet, J; de Leeuw, K; Graaff, R; Kallenberg, CG; Nienhuis, HL; Schalkwijk, CG; Smit, A | 1 |
| Choi, YG; Lim, S | 1 |
| 't Hart, LM; Blaak, EE; de Groot, PG; Dekker, JM; Ferreira, I; Feskens, EJ; Gaens, KH; Heine, RJ; Nijpels, G; Schalkwijk, CG; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
| Ames, JM; Connolly, L; del Castillo, MD; Elliott, CT; Hull, GL; Srey, C | 1 |
| Engelen, L; Ferreira, I; Hovind, P; Parving, HH; Persson, F; Rossing, P; Schalkwijk, CG; Stehouwer, CD; Teerlink, T | 1 |
| Izumi, M; Maruyama, T; Mera, K; Nagai, R; Otagiri, M; Takeo, K | 1 |
| Akileshwari, C; Muthenna, P; Reddy, GB | 1 |
| Andrades, MÉ; Dal-Pizzol, F; Lorenzi, R; Moreira, JC; Nagai, R; Ritter, C | 1 |
| Du, R; Jing, Y; Lu, L; Yang, K; Zhang, R; Zhu, J; Zhu, Z | 1 |
| Brimble, MA; Cooper, GJ; Woods, TM | 1 |
| Engelen, L; Franssen, FM; Gopal, P; Reynaert, NL; Rutten, EP; Schalkwijk, CG; Scheijen, JL; Wouters, EF | 1 |
| Dekker, JM; Engelen, L; Ferreira, I; Hanssen, NM; Huijberts, MS; Nijpels, G; Schalkwijk, CG; Scheijen, JL; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
| Fahlgren, C; Forslund, A; Lindh, CH; Östman, E; Tareke, E | 1 |
| Cheng, L; Dai, M; Jin, C; Lin, Q; Zhang, Y; Zheng, X; Zhou, Y | 1 |
| Fiore, A; Fogliano, V; Troise, AD; Wiltafsky, M | 1 |
| Fiore, A; Troise, AD; Tsang, C; Vitiello, D | 1 |
| Fogliano, V; Troise, AD; Vitaglione, P; Wiltafsky, M | 1 |
1 trial(s) available for n(6)-carboxymethyllysine and n(6)-(1-carboxyethyl)lysine
| Article | Year |
|---|---|
Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.
Topics: Adult; Aged; Albuminuria; Angiotensin Receptor Antagonists; Biomarkers; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycation End Products, Advanced; Humans; Hypertension; Irbesartan; Lysine; Male; Middle Aged; Prognosis; Tetrazoles | 2011 |
32 other study(ies) available for n(6)-carboxymethyllysine and n(6)-(1-carboxyethyl)lysine
| Article | Year |
|---|---|
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Carbohydrate Metabolism; Child; Collagen; Crystallins; Humans; Lens, Crystalline; Lysine; Middle Aged; Oxidative Stress; Pyruvaldehyde; Ribonucleases; Skin | 1997 |
Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Arginine; Cartilage, Articular; Child; Child, Preschool; Collagen; Collagenases; Cross-Linking Reagents; Female; Femur; Glycation End Products, Advanced; Humans; Lysine; Maillard Reaction; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2000 |
Effect of collagen turnover on the accumulation of advanced glycation end products.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arginine; Aspartic Acid; Cartilage, Articular; Child; Child, Preschool; Chondrocytes; Collagen; Glycation End Products, Advanced; Humans; Kinetics; Lysine; Middle Aged; Skin | 2000 |
Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified a
Topics: Aminoquinolines; Biochemistry; Carbamates; Chromatography; Chromatography, High Pressure Liquid; Glucose; Glycation End Products, Advanced; Indicators and Reagents; Lysine; Magnetic Resonance Spectroscopy; Models, Chemical; Temperature; Time Factors | 2002 |
Aging increases Nepsilon-(carboxymethyl)lysine and caloric restriction decreases Nepsilon-(carboxyethyl)lysine and Nepsilon-(malondialdehyde)lysine in rat heart mitochondrial proteins.
Topics: Aging; Animals; Enzyme-Linked Immunosorbent Assay; Fatty Acids; Food Deprivation; Gas Chromatography-Mass Spectrometry; Lysine; Male; Malondialdehyde; Mitochondria; Models, Statistical; Myocardium; Oxidative Stress; Phospholipids; Rats; Rats, Wistar; Reactive Oxygen Species; Time Factors | 2002 |
Oxidative, glycoxidative and lipoxidative damage to rat heart mitochondrial proteins is lower after 4 months of caloric restriction than in age-matched controls.
Topics: Aldehydes; Animals; Biomarkers; Energy Intake; Glutamates; Lysine; Male; Mitochondria, Heart; Mitochondrial Proteins; Oxidative Stress; Rats; Rats, Wistar; Reference Values; Time Factors | 2002 |
Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.
Topics: Adult; Aged; Blood Coagulation Factors; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 1; E-Selectin; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Kidney; Lysine; Male; Middle Aged; Thrombomodulin; Vascular Cell Adhesion Molecule-1 | 2004 |
Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
Topics: Cross-Sectional Studies; Female; Glomerular Filtration Rate; Glucose; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Peritoneal Dialysis; Vascular Cell Adhesion Molecule-1 | 2004 |
Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry.
Topics: Biomarkers; Blood Proteins; Chromatography, Liquid; Glycation End Products, Advanced; Humans; Hydrolysis; Indicator Dilution Techniques; Lipids; Lysine; Mass Spectrometry; Oxidation-Reduction; Renal Dialysis; Renal Insufficiency | 2004 |
The clinical chemome: a tool for the diagnosis and management of chronic disease.
Topics: Biomarkers; Chromatography, Liquid; Chronic Disease; Glycation End Products, Advanced; Humans; Lipid Metabolism; Lipids; Lysine; Mass Spectrometry; Oxidation-Reduction; Renal Dialysis; Renal Insufficiency | 2004 |
Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Topics: Animals; Antibodies, Monoclonal; Cattle; Cross Reactions; Eye Proteins; Glycation End Products, Advanced; Immunization; Immunoglobulin G; Lysine; Rabbits; Serum Albumin, Bovine | 2004 |
Rapid and simple method for determination of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in urine using gas chromatography/mass spectrometry.
Topics: Child; Gas Chromatography-Mass Spectrometry; Glycation End Products, Advanced; Humans; Lysine; Reproducibility of Results; Time Factors | 2005 |
Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.
Topics: Adult; Blood Pressure; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Linear Models; Lysine; Male; Middle Aged; Multicenter Studies as Topic; Platelet Activating Factor; Prospective Studies | 2005 |
Advanced glycation end product deposits in climatic droplet keratopathy.
Topics: Antibodies, Monoclonal; Arginine; Cornea; Corneal Diseases; Cross-Linking Reagents; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Pyrroles | 2007 |
Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.
Topics: Adolescent; Adult; Arginine; Atherosclerosis; Carotid Arteries; Collagen; Female; Glycation End Products, Advanced; Glycogen Storage Disease Type I; Humans; Lysine; Male; Oxidative Stress; Risk; Skin; Tunica Intima; Tunica Media | 2007 |
Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
Topics: Aged; Biomarkers; Female; Follow-Up Studies; Glycation End Products, Advanced; Heart Failure; Humans; Lysine; Male; Middle Aged; Prognosis; Risk Assessment; Risk Factors; Survival Analysis | 2007 |
Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.
Topics: Adult; Case-Control Studies; Female; Fluorescence; Glycation End Products, Advanced; Humans; Lupus Erythematosus, Systemic; Lysine; Male; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Skin; Vascular Cell Adhesion Molecule-1 | 2008 |
Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
Topics: Animals; Antibodies; Arginine; Cattle; Cross Reactions; Glycation End Products, Advanced; Lysine; Rabbits; Serum Albumin, Bovine | 2009 |
Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Topics: Aged; Blotting, Western; Cohort Studies; Creatine; Enzyme-Linked Immunosorbent Assay; Female; Gene Frequency; Glycation End Products, Advanced; Humans; Kidney Function Tests; Lysine; Male; Middle Aged; Netherlands; Phenotype; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2009 |
Effect of inhibitor compounds on Nε-(carboxymethyl)lysine (CML) and Nε-(carboxyethyl)lysine (CEL) formation in model foods.
Topics: Food Analysis; Food Handling; Lysine | 2010 |
An autoantibody against N(ε)-(carboxyethyl)lysine (CEL): possible involvement in the removal of CEL-modified proteins by macrophages.
Topics: Animals; Arginine; Autoantibodies; Glycation End Products, Advanced; Humans; Lysine; Macrophages, Peritoneal; Mice; Rabbits; Serum Albumin | 2011 |
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
Topics: Animals; Crystallins; Diabetes Complications; Ellagic Acid; Gluconates; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lactones; Lens, Crystalline; Lysine; Male; Muramidase; Organ Culture Techniques; Rats; Rats, Wistar; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |
Plasma glycation levels are associated with severity in sepsis.
Topics: Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Kidney Diseases; Lysine; Male; Middle Aged; Prognosis; ROC Curve; Sepsis | 2012 |
The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
Topics: Apoptosis; Cell Movement; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Glycation End Products, Advanced; Humans; Lysine; Mitogen-Activated Protein Kinases; Neovascularization, Physiologic; Phosphorylation; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Stem Cells; Time Factors; Toxins, Biological; Uremia | 2012 |
Synthesis of stable isotope-labelled monolysyl advanced glycation endproducts.
Topics: Diabetes Mellitus; Glycation End Products, Advanced; Isotope Labeling; Lysine; Mass Spectrometry; Norleucine; Pyrroles | 2013 |
Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.
Topics: Aged; Arginine; Case-Control Studies; Female; Fluorescence; Glycation End Products, Advanced; Humans; Inflammation; Lung; Lysine; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Skin; Smoking; Spirometry | 2014 |
Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Lysine; Male; Middle Aged | 2013 |
Isotope dilution ESI-LC-MS/MS for quantification of free and total Nε-(1-Carboxymethyl)-L-Lysine and free Nε-(1-Carboxyethyl)-L-Lysine: comparison of total Nε-(1-Carboxymethyl)-L-Lysine levels measured with new method to ELISA assay in gruel samples.
Topics: Beverages; Chromatography, Liquid; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Isotope Labeling; Lysine; Tandem Mass Spectrometry | 2013 |
Simultaneous analysis of N(ε) -(carboxymethyl)Lysine and N(ε) -(carboxyethyl)lysine in foods by ultra-performance liquid chromatography-mass spectrometry with derivatization by 9-fluorenylmethyl chloroformate.
Topics: Chromatography, Liquid; Fluorenes; Food Analysis; Glycation End Products, Advanced; Humans; Indicators and Reagents; Lysine; Mass Spectrometry; Reproducibility of Results | 2015 |
Quantification of Nε-(2-Furoylmethyl)-L-lysine (furosine), Nε-(Carboxymethyl)-L-lysine (CML), Nε-(Carboxyethyl)-L-lysine (CEL) and total lysine through stable isotope dilution assay and tandem mass spectrometry.
Topics: Chromatography, Liquid; Food Analysis; Indicator Dilution Techniques; Isotopes; Lysine; Protein Conformation; Quality Control; Reproducibility of Results; Tandem Mass Spectrometry | 2015 |
Encapsulation of ascorbic acid promotes the reduction of Maillard reaction products in UHT milk.
Topics: Animals; Ascorbic Acid; Food Handling; Food, Fortified; Glycation End Products, Advanced; Lysine; Maillard Reaction; Mass Spectrometry; Milk | 2016 |
The quantification of free Amadori compounds and amino acids allows to model the bound Maillard reaction products formation in soybean products.
Topics: Amino Acids; Discriminant Analysis; Food Analysis; Food Handling; Glycation End Products, Advanced; Glycine max; Lysine; Maillard Reaction; Mass Spectrometry; Plant Proteins | 2018 |